{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:33:39Z","timestamp":1775165619488,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The angiotensin type 2 receptor plays a unique role in growth inhibition in adult myocardium via modulation of ceramide synthesis. Angiotensin type 1 (<jats:styled-content style=\"fixed-case\">AT<\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>1<\/jats:sub><\/jats:styled-content>)\u2010receptor blockade results in increased angiotensin type 2 receptor activation by angiotensin <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">AT<\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>1<\/jats:sub><\/jats:styled-content>\u2010receptor blockers are sometimes prescribed to children for the treatment of cardiac hypertrophy or heart failure. We investigated the changes of ceramide lipid components in hypertrophied immature rabbit hearts after chronic administration of the <jats:styled-content style=\"fixed-case\">AT<\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>1<\/jats:sub><\/jats:styled-content>\u2010receptor blocker, losartan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One\u2010week\u2010old Japanese white rabbits were randomly divided into three groups: sham\u2010operated control rabbits (Group <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>), rabbits given distilled water orally for 21 days after aortic constriction (Group <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>), and rabbits given losartan orally for 21 days after aortic constriction (Group <jats:styled-content style=\"fixed-case\">H + L<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with Group <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>, the hypertrophy index and left ventricular posterior wall thickness were significantly increased in Group <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>, but were not different in Group <jats:styled-content style=\"fixed-case\">H + L<\/jats:styled-content>. Total myocardial ceramide levels in Group <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content> and Group <jats:styled-content style=\"fixed-case\">H + L<\/jats:styled-content> were suppressed compared with Group <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>. The relative fatty acid components of myocardial ceramide in Group <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content> were the same as those in Group <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>, but Group <jats:styled-content style=\"fixed-case\">H + L<\/jats:styled-content> showed a significant increase in the <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>16<\/jats:sub><\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>:0<\/jats:sub><\/jats:styled-content> component.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The total cardiac ceramide levels are depressed by pressure overload of immature rabbit hearts. Losartan reduced the hypertrophy with selective increase of the relative amount of <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content><jats:styled-content style=\"fixed-case\"><jats:sub>16:0<\/jats:sub><\/jats:styled-content>\u2010ceramide.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ped.12052","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T14:16:25Z","timestamp":1358172985000},"page":"272-276","source":"Crossref","is-referenced-by-count":3,"title":["Modulation of <scp>C<\/scp><scp><sub>16:0<\/sub><\/scp>\u2010ceramide in hypertrophied immature hearts by losartan"],"prefix":"10.1111","volume":"55","author":[{"given":"Toshiyuki","family":"Itoi","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology and Nephrology Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsujiro","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Nephrology Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Hananoki Medical Welfare Center  Kameoka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.6.H2337"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1999.0934"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01675-5"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.24.16901"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5294.1855"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.1359"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)33398-8"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/hh0701.089175"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119360"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.275.3.H906"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248409356430"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0806529"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200202000-00005"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2008.02.003"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0806529"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.43.30580"}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fped.12052","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ped.12052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:54:52Z","timestamp":1697309692000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ped.12052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/ped.12052"],"URL":"https:\/\/doi.org\/10.1111\/ped.12052","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}